Concepedia

Manlio Fusciello

MF

Statistics

Publications

26

Citations

908

H-Index

18

Active since

2016

Affiliations

University of Helsinki(Current)

University of Naples Federico II

Institute for Molecular Medicine Finland

Helsinki University Hospital

Karolinska Institutet

Manlio Fusciello is an author at University of Helsinki specializing in cancer immunotherapy, oncology, and cancer immunology.

ORCID

Publications per year

2016–2024

26

Publications

26

Artificially cloaked viral nanovaccine for cancer immunotherapy

Manlio Fusciello, Flavia Fontana, Siri Tähtinen et al. · Nature Communications · 2019 · 137 citations · Full text

, , +17

Dual-peptide functionalized acetalated dextran-based nanoparticles for sequential targeting of macrophages during myocardial infarction

Giulia Torrieri, Flavia Fontana, Patrícia Figueiredo et al. · Nanoscale · 2019 · 67 citations · Full text

, , +17

Exploiting Preexisting Immunity to Enhance Oncolytic Cancer Immunotherapy

Siri Tähtinen, Sara Feola, Cristian Capasso et al. · Cancer Research · 2020 · 57 citations

, , +17

Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vivo and with patient-derived tumor organoids

Firas Hamdan, Erkko Ylösmäki, Jacopo Chiaro et al. · Journal for ImmunoTherapy of Cancer · 2021 · 53 citations · Full text

, , +17

Characterization of a novel OX40 ligand and CD40 ligand-expressing oncolytic adenovirus used in the PeptiCRAd cancer vaccine platform

Erkko Ylösmäki, Leena Ylösmäki, Manlio Fusciello et al. · Molecular Therapy — Oncolytics · 2021 · 52 citations · Full text

, , +17

1–5 of 26